Cargando…

Implications of Persistent HPV52 and HPV58 Positivity for the Management of Cervical Lesions

OBJECTIVE: This study aimed to compare the variability of HPV16/18/52/58 subtype infections in patients with different cervical lesions, to explore the guiding significance of persistent positive HPV subtypes 52 and 58 in the stratified management of cervical lesions, and to determine the appropriat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yi, Baozhu, Xu, Qian, Zhang, Zhixuan, Zhang, Jinyi, Xu, Yi, Huang, Luoqi, Hu, Yue, Tu, Quanmei, Chen, Jingyun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9175636/ https://www.ncbi.nlm.nih.gov/pubmed/35692793 http://dx.doi.org/10.3389/fonc.2022.812076

Ejemplares similares

Evolution and Taxonomic Classification of Human Papillomavirus 16 (HPV16)-Related Variant Genomes: HPV31, HPV33, HPV35, HPV52, HPV58 and HPV67
por: Chen, Zigui, et al.
Publicado: (2011)

Clinical analysis of HPV58-positive cervical cancer
por: Chen, Mengjie, et al.
Publicado: (2020)

HPV-16, HPV-58, and HPV-33 are the most carcinogenic HPV genotypes in Southwestern China and their viral loads are associated with severity of premalignant lesions in the cervix
por: Long, Wenbo, et al.
Publicado: (2018)

Genetic and Epigenetic Variations of HPV52 in Cervical Precancer
por: Bee, Katharine J., et al.
Publicado: (2021)

L1 and L2 gene polymorphisms in HPV-58 and HPV-33: implications for vaccine design and diagnosis
por: Chen, Zuyi, et al.
Publicado: (2016)

HPV Infection in Cervical and Other Cancers in Saudi Arabia: Implication for Prevention and Vaccination
por: Alsbeih, Ghazi
Publicado: (2014)

Monoclonal antibodies in cervical malignancy-related HPV
por: Aghbash, Parisa Shiri, et al.
Publicado: (2022)

Significance of HPV-58 Infection in Women Who Are HPV-Positive, Cytology-Negative and Living in a Country with a High Prevalence of HPV-58 Infection
por: Song, Joon Seon, et al.
Publicado: (2013)

Analysis of E2 gene integrity in HPV16 and HPV58 viruses isolated from women with cervical pathology
por: González-Losa, María del R, et al.
Publicado: (2016)

HPV16 E7 oncoprotein test as a triage strategy for HPV16-positive women in cervical cancer screening: long-term follow-up outcome
por: Wang, Xinmei, et al.
Publicado: (2023)

Viral load and high prevalence of HR-HPV52 and 58 types in black women from rural communities
por: Volpini, Lays Paula Bondi, et al.
Publicado: (2021)

Genotyping for Human Papillomavirus (HPV) 16/18/52/58 Has a Higher Performance than HPV16/18 Genotyping in Triaging Women with Positive High-risk HPV Test in Northern Thailand
por: Khunamornpong, Surapan, et al.
Publicado: (2016)

The Risk Stratification for Cervical Cancer and Precursors of Domestic HPV Testing With HPV 16/18 Genotyping in Women With NILM Cytology in CentralChina: A Cohort Study
por: Xu, Hui-Fang, et al.
Publicado: (2021)

miR-9, miR-21, miR-27b, and miR-34a Expression in HPV16/58/52-Infected Cervical Cancer
por: Liu, Mi, et al.
Publicado: (2020)

Better or Worse? The Independent Prognostic Role of HPV-16 or HPV-18 Positivity in Patients With Cervical Cancer: A Meta-Analysis and Systematic Review
por: Chen, Xing, et al.
Publicado: (2020)

HPV in HIV-Infected Women: Implications for Primary Prevention
por: McKenzie, Nathalie Dauphin, et al.
Publicado: (2014)

HPV58 E7 Protein Expression Profile in Cervical Cancer and CIN with Immunohistochemistry
por: Zheng, Qiaoli, et al.
Publicado: (2021)

HPV16 E6 Promotes the Progression of HPV Infection-Associated Cervical Cancer by Upregulating Glucose-6-Phosphate Dehydrogenase Expression
por: Chang, Ye-Fei, et al.
Publicado: (2021)

Enhanced disease progression due to persistent HPV-16/58 infections in Korean women: a systematic review and the Korea HPV cohort study
por: Seong, Jaehyun, et al.
Publicado: (2021)

Age and HPV type as risk factors for HPV persistence after loop excision in patients with high grade cervical lesions: an observational study
por: Pirtea, Laurențiu, et al.
Publicado: (2016)

Multiple HPV Infections and Viral Load Association in Persistent Cervical Lesions in Mexican Women
por: Oyervides-Muñoz, Mariel A., et al.
Publicado: (2020)

Preventing Cervical Cancer in the United States: Barriers and Resolutions for HPV Vaccination
por: Beavis, Anna Louise, et al.
Publicado: (2016)

Impact of HR-HPV infection on oncological outcomes in early cervical cancer
por: Su, Xiaoqiang, et al.
Publicado: (2023)

Detection of HPV and Human Chromosome Sites by Dual-Color Fluorescence In Situ Hybridization Reveals Recurrent HPV Integration Sites and Heterogeneity in Cervical Cancer
por: Xiong, Jinfeng, et al.
Publicado: (2021)

Anti-HPV16 oncoproteins siRNA therapy for cervical cancer using a novel transdermal peptide PKU12
por: Deng, Yan, et al.
Publicado: (2023)

The levels of anti-HPV16/18 and anti-HPV31/33/35/45/52/58 antibodies among AS04-adjuvanted HPV16/18 vaccinated and non-vaccinated Ugandan girls aged 10–16 years
por: Nakalembe, Miriam, et al.
Publicado: (2014)

Integration of scRNA-Seq and TCGA RNA-Seq to Analyze the Heterogeneity of HPV+ and HPV- Cervical Cancer Immune Cells and Establish Molecular Risk Models
por: Wei, Erdong, et al.
Publicado: (2022)

Production of Polyclonal Antibody to the HPV58 E7 Protein and Its Detection in Cervical Cancer
por: Zheng, Qiaoli, et al.
Publicado: (2016)

Genetic Variability in L1 and L2 Genes of HPV-16 and HPV-58 in Southwest China
por: Yue, Yaofei, et al.
Publicado: (2013)

Prevalence of HPV infections in surgical smoke exposed gynecologists
por: Hu, Xiaoli, et al.
Publicado: (2020)

Distribution of HPV types associated with cervical cancers in Scotland and implications for the impact of HPV vaccines
por: Cuschieri, K, et al.
Publicado: (2010)

Oral health in HPV-positive and HPV-negative patients with oropharyngeal squamous cell carcinoma
por: Kanzow, Philipp, et al.
Publicado: (2023)

Clearance of persistent HPV infection and cervical lesion by therapeutic DNA vaccine in CIN3 patients
por: Kim, Tae Jin, et al.
Publicado: (2014)

Burden of Human Papillomavirus (HPV)-Related Cancers Attributable to HPVs 6/11/16/18/31/33/45/52 and 58
por: de Sanjosé, Silvia, et al.
Publicado: (2019)

Nimotuzumab Combined With Irradiation Enhances the Inhibition to the HPV16 E6-Promoted Growth of Cervical Squamous Cell Carcinoma
por: Xu, Zhonghua, et al.
Publicado: (2020)

Phylogeny and polymorphism in the E6 and E7 of human papillomavirus: alpha-9 (HPV16, 31, 33, 52, 58), alpha-5 (HPV51), alpha-6 (HPV53, 66), alpha-7 (HPV18, 39, 59, 68) and alpha-10 (HPV6, 44) in women from Shanghai
por: Zhao, Junwei, et al.
Publicado: (2019)

hnRNP E1 Regulates HPV16 Oncogene Expression and Inhibits Cervical Cancerization
por: Song, Li, et al.
Publicado: (2022)

Identification of variants and therapeutic epitopes in HPV-33/HPV-58 E6 and E7 in Southwest China
por: He, Jiaoyu, et al.
Publicado: (2019)

Molecular and Functional Profiles of Exosomes From HPV(+) and HPV(−) Head and Neck Cancer Cell Lines
por: Ludwig, Sonja, et al.
Publicado: (2018)

Construction of an immune-related ceRNA network in cervical cancer based on HPV E6 splicing
por: Jiang, Senwei, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_g7ti14gbklkg84frklfh3g6jip